Hudson Bay Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.7K Buy
2021
Q4
Sell
2021
Q3
$5.04M Hold
2021
Q2
$4.99M Hold
2021
Q1
$4.91M Buy